JohnDavidLonsdaleMD
Ophthalmology • Lewiston, MECataract Related, Oculo-Plastic & Orbital Reconstructive Surgery
Physician
Are you Dr. Lonsdale?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
181 Russell St
Lewiston, ME 04240Phone+1 207-784-1814Fax+1 207-783-3159
Summary
- Dr. John Lonsdale, MD is a board certified ophthalmologist in Lewiston, Maine. He is currently licensed to practice medicine in Maine and Pennsylvania. He is affiliated with St. Mary's Regional Medical Center and Maine Veterans Affairs Medical Center.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Ophthalmology, 1984 - 1985- Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1982 - 1983
- Drexel University College of MedicineClass of 1982
Certifications & Licensure
ME State Medical License 1985 - 2025
PA State Medical License 1984 - 1998- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye Start of enrollment: 2008 Nov 01
- Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 141 citationsLifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Results of the OPUS-1 Phase 3 StudyJohn D. Sheppard, Gail Torkildsen, John Lonsdale, Francis A. D'Ambrosio, Eugene B McLaurin
Ophthalmology. 2014-02-01 - 43 citationsA Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.David Wirta, Gail Torkildsen, Helen R. Moreira, John D. Lonsdale, Joseph B. Ciolino
Ophthalmology. 2019-01-28 - 77 citationsA phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.Charles P. Semba, Gail Torkildsen, John Lonsdale, Eugene B McLaurin, Joel A. Geffin
American Journal of Ophthalmology. 2012-06-01
Professional Memberships
- Fellow
